Semler Scientific: An Important Update for Investors
Semler Scientific, Inc. has been making significant strides in providing innovative technology solutions aimed at enhancing healthcare efficiency. However, the company has also faced some challenges that investors need to be aware of in order to protect their investments. This article will explain the current situation surrounding Semler Scientific, specifically regarding a class action lawsuit that investors can engage with.
Understanding the Current Legal Actions
In the realm of investor rights, there comes a time when individuals must stand strong against potential corporate wrongdoing. For investors in Semler Scientific, now is that crucial time. It has come to light that a class action lawsuit has been initiated against the company, particularly focused on actions taken during the period from March 10, 2021, to April 15, 2025. If you are among those who purchased securities during this timeframe, it is essential to review your legal options for potential recovery.
How to Get Involved
Investors affected by Semler Scientific's actions are encouraged to seek assistance. The Portnoy Law Firm is offering consultations at no charge. They can help you understand how best to proceed with a lead plaintiff motion, especially as the deadline approaches.
Details of the Case
The allegations in the lawsuit revolve around false or misleading statements made by Semler Scientific's management. Specifically, the lawsuit claims that the company failed to disclose a significant investigation launched by the U.S. Department of Justice, which scrutinized potential violations of the False Claims Act. Instead, the defendants reportedly discussed these matters only in hypothetical scenarios, leading to misinformation.
The Impact on Stock Valuation
In connection with the investigations, Semler Scientific revealed that it received a civil investigative demand from the Department of Justice in July. This was regarding the marketing practices of devices utilizing photoplethysmography technology meant for Medicare reimbursements. Following this announcement, the share price of Semler Scientific saw a considerable decline, highlighting the negative impact of the revelations on investor confidence.
Settlement Discussions
In April 2025, Semler Scientific announced that they had reached an agreement in principle to settle claims for approximately $29.75 million. However, the announcement led to another significant drop in stock prices. This situation underlines the necessity for investors to stay vigilant and informed throughout the ongoing proceeding.
Next Steps for Investors
All affected investors are urged to consider their position carefully. Engaging a skilled attorney knowledgeable in securities law is crucial to navigating this situation effectively. The Portnoy Law Firm is available to assist investors in understanding their rights and options.
Contact Information
If you wish to discuss your rights as an investor or require assistance, you can contact Lesley F. Portnoy at the Portnoy Law Firm via phone at 310-692-8883 or by email at lesley@portnoylaw.com. They are here to provide a complimentary case evaluation, helping you understand the best path forward.
Frequently Asked Questions
What is the class action lawsuit about?
The lawsuit alleges that Semler Scientific misled investors regarding a DOJ investigation into the company.
Who can join the class action?
Investors who purchased Semler Scientific securities between March 10, 2021, and April 15, 2025, can join the action.
What should I do if I'm an affected investor?
You should consult with a lawyer to discuss your options and the possibility of recovering losses.
When is the deadline to file a motion?
Investors have until October 28, 2025, to file a lead plaintiff motion.
How can I contact the Portnoy Law Firm?
You can reach them at 310-692-8883 or via email at lesley@portnoylaw.com for inquiries.
